GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2020–FY 2026.

Net obligations$1.29M
Contract actions31
Awards / PIIDs20
Federal customers5
Contracting offices7
Average action$41.5K
Active fiscal years5
Data coverageFY 2020–FY 2026

Across FY 2020–FY 2026, FPDS records attribute $1.29M in net contract obligations to KAPA BIOSYSTEMS, INC. across 31 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

KAPA BIOSYSTEMS, INC. contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations-$916
FY 2024
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2020$469.9K115—
FY 2021$577.9K62+23.0%
FY 2022$246.0K102−57.4%
FY 2023-$5.8K33−102.4%
FY 2024-$91611+84.3%

04 / Federal Customers

Which federal agencies buy from KAPA BIOSYSTEMS, INC.?

Ranked by net obligations during FY 2020–FY 2026.

AgencyCodeObligationsActionsVendor share
2100$1.12M1587.0%
7529$157.1K1112.2%
3300$6.3K10.5%
7523$4.6K20.4%
1549-$9082-0.1%

05 / Contracting Offices

Which contracting offices buy from KAPA BIOSYSTEMS, INC.?

Ranked by net obligations during FY 2020–FY 2026.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
334516ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING$1.14M19488.3%
811219OTHER ELECTRONIC AND PRECISION EQUIPMENT REPAIR AND MAINTENANCE$137.6K3110.7%
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$19.9K411.5%
541711RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY-$322210.0%
325412PHARMACEUTICAL PREPARATION MANUFACTURING-$90821-0.1%
541714RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)-$5.8K11-0.4%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
6640LABORATORY EQUIPMENT AND SUPPLIES$828.2K16464.3%
6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$295.4K4123.0%
Q301MEDICAL- LABORATORY TESTING$137.6K3110.7%
6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$19.9K511.5%
H166QUALITY CONTROL- INSTRUMENTS AND LABORATORY EQUIPMENT$6.3K110.5%
6505DRUGS AND BIOLOGICALS-$306210.0%

08 / Competition Pattern

How was KAPA BIOSYSTEMS, INC.’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Other / unknown$1.13M19
Competed under SAP$18.9K8
Not available for competition$137.6K4

09 / Recent Contract Awards

What contract actions were recorded most recently for KAPA BIOSYSTEMS, INC.?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
75N92E20P00011Nov 17, 2023-$916NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NHGRI3254146550

10 / Interpreting the Profile

How should you evaluate KAPA BIOSYSTEMS, INC. as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.